Actively Recruiting

Phase Not Applicable
Age: 55Years +
All Genders
ID05564091

Cataract Surgery With Ab-interno Canaloplasty Using iTrack Advance Compared to Cataract Surgery Alone in Mild to Moderate Primary Open-Angle Glaucoma

Led by Nova Eye, Inc. · Updated on 2025-04-18

78

Participants Needed

4

Research Sites

4 weeks

Total Duration

On this page

Sponsors

N

Nova Eye, Inc.

Lead Sponsor

N

Nova Eye Medical GmbH

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating cataract surgery combined with ab-interno canaloplasty using the iTrack Advance canaloplasty device compared to cataract surgery alone in patients with mild to moderate primary open-angle glaucoma. This prospective, multicenter, randomized, single-masked clinical trial aims to assess the effects of these treatments on eye pressure and glaucoma medication use over a two-year period. Participants will be randomly assigned to one of two groups: cataract surgery with ab-interno canaloplasty, which involves 360-degree microcatheterization and viscodilation of Schlemm's canal using the iTrack Advance device, or cataract surgery alone. The study will monitor the impact of these procedures on intraocular pressure and the number of glaucoma medications needed. During the 24-month follow-up, participants will undergo regular assessments to measure changes in intraocular pressure and medication use at 12 and 24 months compared to baseline. The study will also track safety and treatment effects. Participants can expect scheduled visits to monitor eye health and study outcomes throughout their involvement.

CONDITIONS

Brief Title

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

Who Can Participate

Age: 55Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Mild to moderate primary open angle glaucoma
  • Characteristics consistent with mild to moderate glaucoma
  • Use of 1 to 4 ocular hypotensive medications at screening
  • Presence of a visually significant cataract
Not Eligible

You will not qualify if you...

  • Prior laser trabeculoplasty in the study eye
  • Prior endocyclophotocoagulation or micropulse laser in the study eye
  • Prior iStent or iStent Inject in the study eye
  • Prior Hydrus Microstent in the study eye
  • Prior trabeculectomy or other bleb-forming procedures including Xen, Express, or glaucoma drainage devices
  • Prior canaloplasty (ab-interno or ab-externo) in the study eye
  • Prior goniotomy or trabeculotomy (ab-interno or ab-externo) in the study eye
  • Prior suprachoroidal stent (e.g., Cypass, iStent Supra, XEN, MINIject) in the study eye
  • Concurrent intraocular pressure-lowering procedures other than iTrack Advance at the time of surgery
  • Previous treatment with iTrack in the study eye (permitted if only the fellow eye was treated)
  • Diagnosis of acute angle closure, traumatic, congenital, malignant, uveitic, or neovascular glaucoma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - 1 day to 1 week

Participants undergo cataract surgery, either alone or combined with ab-interno canaloplasty using the iTrack Advance device, followed by immediate post-operative care.

1 surgery visit and approximately 2 post-operative visits

Post-operative Follow-up

Duration - Up to 24 months

Participants attend follow-up visits to monitor recovery, intraocular pressure, and medication use after surgery.

Regular follow-up visits over 24 months

Trial Site Locations

Total: 4 locations

1

Berkeley Eye Center

Sugar Land, Texas, United States, 77478

Actively Recruiting

2

University of Bonn Eye Clinic

Bonn, Germany

Actively Recruiting

3

Augencentrum Köln Ophthalmology

Cologne, Germany

Actively Recruiting

4

St. Johannes Hospital

Dortmund, Germany

Actively Recruiting

Loading map...

Research Team

M

Mike Pickrel

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Prospective Study on the Efficacy of Direct Selective Lase...

Primary Open Angle Glaucoma

Actively Recruiting

1 location

Phase 2 Randomized Open Label Study of AMDX-2011P as a Retin...

Primary Open Angle Glaucoma

Actively Recruiting

3 locations

A Pilot Study of the Helix Surgical System in Subjects With ...

Primary Open Angle Glaucoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here